Development of a Soluble KIT (sKIT) Electrochemical Aptasensor For Cancer Theranostics
Preprint
Abstract
A conformational changing aptamer based electrochemical sensor was developed for the detection of soluble KIT, a cancer biomarker, in human serum. The sensor was fabricated with a ferrocene labeled aptamer ( K d < 5 nM) conjugated to a gold electrode. Quantitative KIT detection was performed using electrochemical impedance spectroscopy (EIS) and square wave voltammetry (SWV). The experimental parameters such as the ratio of aptamer to spacer, aptamer immobilization time, pH, and KIT incubation time were optimized by EIS, and the sensing surface was characterized with voltammetry. The assay specificity was investigated using interfering species showing high specificity towards the target protein. The aptasensor exhibited a wide dynamic range from 10 pg/mL to 100 ng/mL in buffer with a detection limit of 1.15 pg/mL. The sensor also exhibited a linear response with increased KIT concentrations spiked in human serum. The applicability of the sensor was successfully demonstrated using cancer cell conditioned media. The proposed aptasensor can be used in continuous or intermittent approach for cancer therapy monitoring and diagnostics (theranostics).Keywords
All Related Versions
- Published version: ACS Sensors, 6 (5), 1971.
This publication has 50 references indexed in Scilit:
- Simply amplified electrochemical aptasensor of Ochratoxin A based on exonuclease-catalyzed target recyclingBiosensors and Bioelectronics, 2011
- The application of DNA and RNA G-quadruplexes to therapeutic medicinesChemical Society Reviews, 2011
- Switch-based biosensors: a new approach towards real-time, in vivo molecular detectionTrends in Biotechnology, 2011
- In vitro selection of structure-switching, self-reporting aptamersProceedings of the National Academy of Sciences, 2010
- Folding-Based Electrochemical Biosensors: The Case for Responsive Nucleic Acid ArchitecturesAccounts of Chemical Research, 2010
- Circulating Levels of Soluble KIT Serve as a Biomarker for Clinical Outcome in Gastrointestinal Stromal Tumor Patients Receiving Sunitinib following Imatinib FailureClinical Cancer Research, 2009
- Stem cell factor and its soluble receptor (c-kit) in serum of asthmatic patients- correlation with disease severityBMC Pulmonary Medicine, 2009
- Circular dichroism and conformational polymorphism of DNANucleic Acids Research, 2009
- CA125 in Ovarian CancerBiomarkers in Medicine, 2007
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990